Legal500

Olswang

BLUE TOWER, AVENUE LOUISE 326, BOX 26, 1050 BRUSSELS, BELGIUM

Reading, Paris, Madrid, London, Brussels, Berlin

What we say about this firm…
What the firm says…

What we say about the firm's legal practice in Belgium

Competition

Olswang’s Koen Platteau is ‘extremely knowledgeable on competition law matters, both Belgian and European, yet very pragmatic in his approach’. Clients include the European Commission and Belgacom. Dirk van Liederkerke is also recommended.

Intellectual property

Within Intellectual property,

Howrey LLP’s work included a cross-border patent infringement case for DSM in defending a patent infringement claim by Novozymes; whilst pharmaceutical work includes work for UCB on premature generic versions of key products. The practice fought a case before the Belgian Supreme Court on patent infringement by Novartis for client GSK. However, Carl De Meyer Benoît Strowel, Fabienne Brison and Steven Cattoor announced the formation of the Brussels office of Hoyng Monegier LLP. Maarten Meulenbelt, whose work spans IP and antitrust, remains with the firm; Patricia Cappuyns earlier joined Olswang.

Legal market overview

Within Legal market overview,

2010 has seen further lateral moves, particularly amongst competition law firms, including Simon Baxter’s move to Skadden, Arps, Slate, Meagher & Flom LLP. Squire, Sanders & Dempsey (UK) LLP also saw the arrival of trade lawyer Robert MacLean from Crowell & Moring. Elsewhere, Lydian was joined by Patrick della Faille; Field Fisher Waterhouse welcomed Thierry Van Innis from Allen & Overy LLP. Howrey LLP saw the departure of four IP partners to Hoyng Monegier LLP and Patricia Cappuyns to Olswang. On the competition side, it saw the exit of Lars Kjølbye and Peter Camesasca to Covington & Burling LLP, and Martina Meier to McDermott Will & Emery/Stanbrook LLP.

What we say worldwide

Please choose another Olswang office to view full details of what we say in that region, or choose from this list to view a specific editorial reference in context.

Belgium

Offices in Brussels

Germany

Offices in Berlin

Spain

Offices in Madrid

Corporate and M&A : Corporate and M&A

London

Offices in London

South East

Offices in Reading

Search News and Articles

Legal Developments in Belgium

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to

Gaming & Gambling Law Newsletter January 2012

Judgment in the Rank Group plc cases (C-259/10 and C-260/10): interpretation of the principle of fiscal neutrality applied to gambling

- ALTIUS (in cooperation with Tiberghien)
FSMA MiFID Action Plan announced

Like in many of our neighboring countries, the Belgian Financial Services and Markets Authority (FSMA) is taking a more persistent approach in pursuing compliance with MiFID conduct of business. In that regard it has announced a “MiFID Action Plan”.

- Liedekerke Wolters Waelbroeck Kirkpatrick
International mobility - limited access to the Belgian labour market

Bulgarian and Romanian workers still need a work permit until 31 December 2013.

- Claeys & Engels, member of Ius Laboris
Modification of the dismissal rules as from 1 January!

Claeys & Engels has updated the calculation modules on www.formuleclaeys.be. Higher level white-collar employees who enter into service after 1 January 2012 will, in the event they are dismissed, be entitled to a notice period, calculated on the basis of the IPA Act. The new notice period amounts to 30 days per started year in service, with a minimum of 91 days.

- Claeys & Engels, member of Ius Laboris
Social elections 2012: Day X-35 (between 3 and 16 January)

On day X-35 at the latest, the employer must announce several decisions. The latter may be subject to appeal before the labour tribunal at the latest on day X-28.

- Claeys & Engels, member of Ius Laboris
Enantiomers and race-mates: the same product?

On October 3 2011 the Brussels Commercial Court invalidated Lundbeck's supplementary protection certificate (SPC) for escitalopram, the 'S' enantiomer of its racemate citalopram. The court held that escitalopram is the same product as citalopram, and that the former's SPC did not comply with Articles 3(c) and (d) of EU Regulation 469/2009. The court held that it was in the interests of patients to declare the decision provisionally enforceable.

- ALTIUS (in cooperation with Tiberghien)
Employment Law News Flash

Another year draws to its close. At the eleventh hour, a government was formed, a budget was agreed and political pledges were made to tackle the current adverse economic and financial climate. The year-end - traditionally a busy period with the issuing of hefty Programme Statutes - marks the beginning of intensified law-making under the reign of Di Rupo I.

- ALTIUS (in cooperation with Tiberghien)
Towards a new dismissal regime

The new regime of dismissal compensation must be simple and should in no way lead to a cost increase for employers. Unnecessary procedures before the courts must be avoided. The purchasing power of the dismissed individuals must be maintained.

- Claeys & Engels, member of Ius Laboris
The Dutch 30 % -rule: change for Belgium

The Dutch second Chamber recently approved some important changes with respect to the conditions for the Dutch fiscal 30 %-rule. As a result, this rule will in practice no longer be available for Belgians.

- Claeys & Engels, member of Ius Laboris
New salary thresholds for white-collar workers

As every year, the Federal Public Service Employment has adapted the thresholds of remuneration to be taken into consideration for the application of certain provisions of the employment contract for white-collar workers.

- Claeys & Engels, member of Ius Laboris